Please login to the form below

Not currently logged in
Email:
Password:

Cipla names Adil Zainulbhai to board

He has experience at consulting firm McKinsey & Company
Adil-Zainulbhai-Cipla

India-based pharma company Cipla has appointed Adil Zainulbhai to its board as an independent director.

A native of India Zainulbhai moved to the US in 1979 to join consulting firm McKinsey & Company. He returned to Mumbai in 2004 to help grow the company's presence in India, working with CEOs of many of the country's largest firms across several industries.

Cipla chairman Y K Hamied said: "Adil's 30 plus years of experience across various industries in India and globally will add a valuable perspective to our board of directors."

Zainulbhai said: "Cipla has had a huge impact in providing affordable pharmaceuticals to the world while building a strong company. I look forward to helping Cipla become even more successful."

29th July 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics